Glenmark launches Nitric Oxide Nasal Spray (FabiSpray®) in India for treatment of adult patients with COVID-19, with SaNOtize. It received manufacturing-marketing approval from India’s drug regulator for Nitric Oxide Nasal Spray as part of accelerated approval process.
Comments are closed here.